Stephen Hoge Moderna, Inc. (MRNA) insider trading activity

Stephen Hoge is President of Moderna, Inc.. Currently has a direct ownership of 1.44 Million shares of MRNA, which is worth approximately $53.2 Million. The most recent transaction as insider was on Nov 11, 2024, when has been sold 277 shares (Common Stock) at a price of $46.1 per share, resulting in proceeds of $12,769. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.44M

0.06% 3M change

8.33% 12M change

Total Value Held $53.2 Million

Stephen Hoge Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 11 2024	SELL Open market or private sale	$12,769 $46.1 p/Share	277 Reduced 0.02%	1,443,248 Common Stock
Nov 08 2024	BUY Exercise of conversion of derivative security	-	523 Added 0.04%	1,443,525 Common Stock
Sep 03 2024	SELL Open market or private sale	$24,482 $76.99 p/Share	318 Reduced 0.02%	1,443,002 Common Stock
Aug 30 2024	BUY Exercise of conversion of derivative security	-	652 Added 0.05%	1,443,320 Common Stock
Aug 29 2024	SELL Open market or private sale	$23,409 $78.03 p/Share	300 Reduced 0.02%	1,442,668 Common Stock
Aug 28 2024	BUY Exercise of conversion of derivative security	-	611 Added 0.04%	1,442,968 Common Stock
Aug 12 2024	SELL Open market or private sale	$21,361 $84.1 p/Share	254 Reduced 0.02%	1,442,357 Common Stock
Aug 09 2024	BUY Exercise of conversion of derivative security	-	522 Added 0.04%	1,442,611 Common Stock
Jul 15 2024	SELL Open market or private sale	$1,816,800 $121.12 p/Share	15,000 Reduced 1.03%	1,442,089 Common Stock
Jun 17 2024	SELL Open market or private sale	$2,072,400 $138.16 p/Share	15,000 Reduced 1.02%	1,457,089 Common Stock
Jun 03 2024	SELL Open market or private sale	$47,704 $140.72 p/Share	339 Reduced 0.02%	1,472,089 Common Stock
May 31 2024	BUY Exercise of conversion of derivative security	-	651 Added 0.04%	1,472,428 Common Stock
May 29 2024	SELL Open market or private sale	$49,274 $144.5 p/Share	341 Reduced 0.02%	1,471,777 Common Stock
May 28 2024	BUY Exercise of conversion of derivative security	-	610 Added 0.04%	1,472,118 Common Stock
May 15 2024	SELL Open market or private sale	$1,912,350 $127.49 p/Share	15,000 Reduced 1.01%	1,471,508 Common Stock
May 10 2024	SELL Open market or private sale	$30,844 $120.96 p/Share	255 Reduced 0.02%	1,486,508 Common Stock
May 09 2024	BUY Exercise of conversion of derivative security	-	522 Added 0.04%	1,486,763 Common Stock
Apr 15 2024	SELL Open market or private sale	$1,575,300 $105.02 p/Share	15,000 Reduced 1.0%	1,486,241 Common Stock
Mar 15 2024	SELL Open market or private sale	$1,547,550 $103.17 p/Share	15,000 Reduced 0.99%	1,501,241 Common Stock
Mar 04 2024	SELL Open market or private sale	$29,151 $94.34 p/Share	309 Reduced 0.02%	1,516,241 Common Stock
Mar 01 2024	BUY Exercise of conversion of derivative security	-	652 Added 0.04%	1,516,550 Common Stock
Feb 29 2024	SELL Open market or private sale	$225,833 $94.57 p/Share	2,388 Reduced 0.16%	1,515,898 Common Stock
Feb 28 2024	BUY Exercise of conversion of derivative security	-	4,853 Added 0.32%	1,518,286 Common Stock
Feb 22 2024	SELL Open market or private sale	$1,500,000 $100.0 p/Share	15,000 Reduced 0.98%	1,513,433 Common Stock
Feb 16 2024	SELL Open market or private sale	$936,972 $88.88 p/Share	10,542 Reduced 0.69%	1,528,433 Common Stock

Also insider at

AXLA

Axcella Health Inc. Healthcare

Director

Stephen Hoge

President

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MRNA shares.

Notify only if

Value

Insider Trading

Get notified when an Moderna, Inc. insider buys or sells MRNA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Moderna, Inc.

Track Activities on MRNA

Account